Caris Life Sciences, Inc. (CAI)
NASDAQ·Healthcare·Biotechnology
$34.24
-5.26%
Mkt Cap $9.05B
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (13 analysts)
$26.00
Range $21.00 – $33.00
Implied Upside
-24.1%
Consensus $26.00 vs current $34.24
NASDAQ·Healthcare·Biotechnology
$34.24
-5.26%
Mkt Cap $9.05B
Buy
11
Hold
1
Sell
0
Price Target (13 analysts)
$26.00
Range $21.00 – $33.00
-24.1%
Consensus $26.00 vs current $34.24